Financials

  • Market Capitalization 18.77 M
  • Employee 8
  • Founded 2021
  • CEO N/A
  • Website www.allarity.com
  • Headquarter Delaware, United States
  • FIGI BBG012NXCZP8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.38
Rapporto prezzo/fatturato
48.53

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4637
ATOS
Atossa Therapeutics, Inc. - Common Stock
2.24 USD-6.67%-10.04%-10.76%+138.30%19.29 M USD
4638
LPCN
Lipocine Inc. - Common Stock
2.31 USD-1.70%-3.35%+2.21%-20.34%19.04 M USD
4643
JSPR
Jasper Therapeutics, Inc. - Class A Common Stock
0.71 USD+16.39%+47.92%+57.78%-79.71%19.88 M USD
4646
NCEL
NewcelX Ltd. - Ordinary Shares
3.98 USD-0.50%+0.51%+20.61%-21.65%19.09 M USD

Notizie